Top

Published in:

01-08-2011 | Letter

Mediastinal lymphadenopathy: assessing clinical utility of EUS-FNA

Author: Charalambos Batsis

Published in: Surgical Endoscopy | Issue 8/2011

Excerpt

In day-to-day clinical practice, oncologists often face the problem of how to manage patients whose mediastinal lymph nodes have increased in size. The diagnostic accuracy of lymph nodes is a general problem given that lymph nodes larger than 0.5–1 cm are not essentially affected by cancer and, in contrast, smaller lymph nodes may contain micrometastatic disease. In practice, preoperative treatment staging with endoscopic ultrasound (EUS), computed tomography, and positron emission tomography is associated with modest predictive accuracy, and pretreatment staging without histopathological examination of surgical specimen is inappropriate. …

Hirdes MM, Schwartz MP, Tytgat KM, Schlösser NJ, Sie-Go DM, Brink MA, Oldenburg B, Siersema PD, Vleggaar FP (2010) Performance of EUS-FNA for mediastinal lymphadenopathy: impact on patient management and costs in low-volume EUS centers. Surg Endosc 24(9):2260–2267PubMedCrossRef

Roukos DH (2009) Isolated tumor cells in breast cancer. N Engl J Med 361:1994–1995 author reply 1995–1996PubMedCrossRef

Roukos DH, Paraschou P, Lorenz M (2000) Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol 7(10):719–726PubMedCrossRef

Katsios GC, Baltogiannis G, Roukos DH (2010) Laparoscopic surgery for gastric cancer: comparative-effectiveness research and future trends. Expert Rev Anticancer Ther 10(4):473–476PubMedCrossRef

Liakakos T, Roukos D (2008) Laparoscopic gastrectomy: advances enable wide clinical application. Surg Endosc 22(6):1553–1555PubMedCrossRef

Liakakos T, Roukos DH (2008) Is there any long-term benefit in quality of life after laparoscopy-assisted distal gastrectomy for gastric cancer? Surg Endosc 22(5):1402–1404PubMedCrossRef

Ziogas D, Roukos D (2008) Robotic surgery for rectal cancer: may it improve also survival? Surg Endosc 22(5):1405–1406PubMedCrossRef

Roukos DH (2010) Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance. Ann Surg Oncol 17:14–17PubMedCrossRef

Ziogas D, Roukos DH (2009) CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer? Ann Surg Oncol 16(10):2678–2681PubMedCrossRef

10.

Katsios C, Roukos DH (2010) Individual genomes and personalized medicine: life diversity and complexity. Pers Med 7(4):347–350CrossRef

11.

Roukos DH (2010) Systems medicine: a real approach for future personalized oncology? Pharmacogenomics 11(3):283–287PubMedCrossRef

12.

Roukos DH (2010) Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev Mol Diagn 10(1):33–48PubMedCrossRef

13.

Roukos DH, Kappas AM, Agnantis NJ (2003) Perspectives and risks of breast-conservation therapy for breast cancer. Ann Surg Oncol 10:718–721PubMedCrossRef

14.

Roukos DH, Kappas AM, Tsianos E (2002) Role of surgery in the prophylaxis of hereditary cancer syndromes. Ann Surg Oncol 9(7):607–609PubMedCrossRef

15.

Roukos DH (2010) Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks. Pharmacogenomics J. doi:10.1038/tpj.2010.81

16.

Roukos DH (2011) Cancer genome explosion and systems biology: impact on surgical oncology? Ann Surg Oncol 18(1):12–15PubMedCrossRef

17.

Roukos DH (2010) Next-generation sequencing and epigenome technologies: potential medical applications. Expert Rev Med Dev 7(6):723–726CrossRef

18.

Roukos DH (2010) Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics 11(8):1039–1043PubMedCrossRef

19.

Roukos DH (2010) Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice. Biomark Med 4(4):583–586PubMedCrossRef

20.

Roukos DH, Katsios C, Liakakos T (2010) Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn 10(5):541–545PubMedCrossRef

21.

Roukos DH (2010) Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn 10(3):247–250PubMedCrossRef

22.

Roukos DH, Ziogas D (2010) From tumor size and HER2 status to systems oncology for very early breast cancer treatment. Expert Rev Anticancer Ther 10(2):123–128PubMedCrossRef

23.

Roukos DH, Tzakos A, Zografos G (2009) Current concerns and challenges towards tailored anti-angiogenic therapy in cancer. Expert Rev Anticancer Ther 9(10):1413–1416PubMedCrossRef

24.

Roukos DH (2009) Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology. Ann Surg 249(6):1067–1068PubMedCrossRef

25.

Roukos DH, Lykoudis E, Liakakos T (2008) Genomics and challenges toward personalized breast cancer local control. J Clin Oncol 26(26):4360–4361PubMedCrossRef

Title: Mediastinal lymphadenopathy: assessing clinical utility of EUS-FNA
Author: Charalambos Batsis
Publication date: 01-08-2011
Publisher: Springer-Verlag
Published in: Surgical Endoscopy / Issue 8/2011
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI: https://doi.org/10.1007/s00464-011-1575-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Mediastinal lymphadenopathy: assessing clinical utility of EUS-FNA

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2011

Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients

Long-term outcome of hybrid surgical approach of video-assisted minithoracotomy sleeve lobectomy for non-small-cell lung cancer

Early surgeon impressions and technical difficulty associated with laparoendoscopic single-site surgery: a Society of American Gastrointestinal and Endoscopic Surgeons learning center study

Colonoscopy for colonic wall thickening at computed tomography: a worthwhile pursuit?

Endoscopic mucosal resection using a cap-fitted panendoscope and endoscopic submucosal dissection as optimal endoscopic procedures for superficial esophageal carcinoma

Modification of laparoscopic subtotal cholecystectomy